EGFR and non-small cell lung carcinoma: Furthermore, it is known, that paclitaxel shows anticancer effects against NSCLC by activating apoptosis through enhancing ROS generation, inducing cell cycle arrest, and suppressing EGFR/PI3K/AKT/mTOR signaling pathway [45].